Isobe, K., Hata, Y., Tochigi, N., Kaburaki, K., Kobayashi, H., Makino, T., . . . Homma, S. (2014). Clinical Significance of BIM Deletion Polymorphism in Non–Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation. Lippincott Williams & Wilkins.
Chicago Stili AlıntıIsobe, Kazutoshi, et al. Clinical Significance of BIM Deletion Polymorphism in Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation. Lippincott Williams & Wilkins, 2014.
MLA AlıntıIsobe, Kazutoshi, et al. Clinical Significance of BIM Deletion Polymorphism in Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation. Lippincott Williams & Wilkins, 2014.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..